There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.

This incentivizes long-term holding, contributing to market stability. The post Elon Musk's Pepe Meme Tweet Turns $1,000 Into a Fortune – Could PEPE 100x From Here? appeared first on Cryptonews.

whose tweets can often have an outsized impact on their market capitalization. Emerging in 2013, Dogecoin was created as a playful tribute to the popular Shiba Inu dog meme. Unlike Bitcoin ...

Adam Spatacco has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Johnson & Johnson, Moderna, and Novo Nordisk.

On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...

The company is currently developing a promising weight management drug called VK2735, which targets the same receptors as Eli Lilly’s successful drug, Tirzepatide. VK2735 is a dual agonist that ...

Lamar Jackson did apologize in advance. The Baltimore Ravens quarterback joked in practice this week that he'd find a way to watch Beyonce's halftime performance in Houston during the team's ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.1%. Elsewhere ...